Reactor Ready Mini: A Compact Small Lab Reactor for Faster Process Development The Radleys Reactor-Ready Mini is a compact, small jacketed reactor supporting 50 ml to 500 ml vessels with accurate temperature control, efficient stirring, dosing, and a scalable process. Reactor-Re... Glass reactors Parallel synthesis Synthesis Continue reading
Beckman Coulter introduces a new (BAT) Basophil Activation Test to Improve Allergy Research Beckman Coulter Life Sciences introduces the Next-Generation Basophil Activation Test (BAT) * to more effectively characterize food allergies without exposure to potentially harmful allergens. * RUO f... Flow cytometry analyzers for research Flow cytometry reagents Continue reading
New Exclusive Partnership with GeneMind Biosciences Analis Expands End to End Next Generation Sequencing Capabilities for Benelux Laboratories with GeneMind Biosciences. This new exclusive partnership between Analis and GeneMind is built on a shared be... DNA / RNA (Nucleic acids) Next Generation Sequencing (NGS) Continue reading
Radleys NEW AVA Pad Reactor Controller AVA Pad Reactor Controller One Box. Any Reactor. Effortless Automation. AVA Pad is a compact, subscription-free, out-of-the-box controller that brings effortless automation to any jacketed lab reactor... Glass reactors Parallel synthesis Synthesis Continue reading
NEW EXCLUSIVE PARTNERSHIP with ACOERELA New Partnership Announcement We are thrilled to announce our new partnership with Acoerela ! Their breakthrough probes and reference standards are setting a new benchmark in clarity and precision for ... Flow cytometry reagents Continue reading
Beckman Coulter & Rarity Bioscience Partnership Brings Molecular Research to Flow Cytometry superRCA® technology is a highly specific molecular assay for ultra-sensitive MRD evaluation, enabling rapid & simultaneous analysis of single or multiple DNA mutations using flow cytometry. This solu... Flow cytometry analyzers for research Flow cytometry reagents Continue reading
Analis Enters Strategic Partnership with PixCell Medical to Expand POCT Hematology Offering Analis is proud to announce a new partnership with PixCell Medical , an innovator in point-of-care hematology testing. This collaboration brings the HemoScreen™ , the first FDA-cleared, IVDR CE-mark-a... Hematology POCT Continue reading
Analis has decided to invest in different disruptive POCT technologies We are thrilled to announce that Analis has made a significant investment in the latest Point-of-Care Testing (POCT) technologies to support diagnostic laboratories and healthcare professionals in obt... POCT POCT RT-PCR Molecular Diagnostics Continue reading